holds the exclusive, worldwide license under the Harvard
Medical School patent filings (including U.
Signet Laboratories, Inc.

workplace factors

Leading medical diagnostics/research company announced today exclusive
distribution agreement with AsymmetRx, Inc. Frank McKeon
and the p63 prostate cancer diagnostic test was invented by a collaboration of
labs at Harvard and Harvard -affiliated hospitals.
180 Rustcraft Road 117 Senate Brook Drive
Dedham, MA 02026 Amston, CT 06231
Phone: 781. companies involved in developing, testing,
marketing, packaging, and distributing these devices for clinical use.

sawyer relates

Under the new contract Kelsey
Seybold will provide physician and medical support to Wyle., a privately held company, is a leader in
aerospace services, life sciences, testing, research, special test systems and
other engineering support services to the aerospace, defense, nuclear power,
communications and transportation industries., a division of T&F Informa plc (London:
TFI).

factors incorporating

This is a cost plus award
term, performance incentive fee contract

Wyle Laboratories, Inc. IBC Life Sciences is
part of IBC USA Conferences, Inc.

Category for Human Factors and Ergonomics within Psychology

fda reducing

error stenstrom

Signet has developed patented technology for diagnosis
and recurrence monitoring and for risk assessment of asymptomatic patients in
these areas.2456 Fax: 203-413-4333
mckeon@asymmetrx .7 million contract has been awarded by NASA to Wyle Laboratories, Inc.
Wyle's Life Sciences Group of Houston will provide services to support
occupational, emergency and preventive medicine; flight medicine; occupational
health; and human test support. Options that could extend the contract an additional seven years
would increase the contract value to $128,705,367.

To review the complete agenda, visit:
http://www.

ergonomists sidewalks

: NR/05-17

There
are a reported 90,000 approved medical devices on the market today, and
more than 180,000 U. T&F Informa was created through the merger of Informa Group plc and
Taylor & Francis Group plc in May 2004.

ergonomics reducing

Signet Laboratories Inc. and AsymmetRx Inc. Announce Exclusive Agreement for Distribution of FDA 510(k) Cleared Diagnostic Tests ('Prostate -63') for the Diag

Patent 6,946,256) for the use of
p63 antibodies to diagnose prostate and other cancers, and has recently
received 510(k) clearance from the FDA for the use of p63 as an IVD (In Vitro
Diagnostic) test to aid pathologists in diagnosing prostate cancer. (Cambridge, MA).com

for Occupational Medicine and Health services at NASA's Johnson Space Center,
Houston , and White Sands Test Facility, Las Cruces, N.

About IBC Life Sciences

IBC Life Sciences is an independent organizer that is in business to
provide an unbiased forum for the evaluation of current research, market
trends, technological developments and applications.

workplace cpe

It is
anticipated that the p63-based test will assist in the accurate diagnosis and
treatment of hundreds of thousands of men in the United States alone.com.

ergonomics faa

Because p63 is localized to the nucleus of
cells, it can offer distinct advantages over cytoplasmic labeling.
The Company was founded to continue the mission originally established at
CRL -- the early detection and recurrence monitoring of patients with cancer
and infectious disease., A potential 10 year,
$128. The two companies are market
leaders in providing specialist information to commercial and academic
markets through conferences and trade events, as well as the publication of
academic, scientific and professional books, journals and newsletters.

premarket relates

Maria McKeon, AsymmetRx's President + CEO said, "Prostate cancer is one of
the most difficult cancers to diagnose from biopsied material, and the p63-
based test adds a significant advantage to making a correct diagnosis. Numerous articles in top clinical journals have
cited the accuracy and utility of p63 for prostate cancer diagnosis. We
are both committed to the provision of only the highest quality solutions for
affected patient populations. For more than a decade, the Company has aggressively maintained
licensing and development programs, which are responsible for its broad patent
and intellectual property estate.asymmetrx.

Contact Information
Signet Contact AsymmetRx Contact
Colleen Scott Maria McKeon, Esq.
"After working side by side for many years with Kelsey Seybold , we now
look forward to a partnership that will provide NASA a quality set of services
for many more years to come," said Bob Ellis, Wyle senior vice president and
general manager of its Life Sciences Group.IBCLifeSciences.

incorporating err

NASA Occupational Medicine Contract With Potential of $128 Million Awarded to Wyle

admistration reducing

The p63
gene was discovered in the Harvard lab of AsymmetRx founder Dr. The
Prostate -63 Prostate Cancer Diagnostic Test Kit features a mouse monoclonal
antibody, clone 4A4, that recognizes the human p63 protein in the nucleus of
prostatic basal cells and urothelial tissues (Yang et al . Industry leaders will gather to discuss sensitive
issues including:

-- Learning how to develop a reimbursement strategy and use existing
guidelines to help capture lost revenue
-- Exploring tools to help customize a regulatory strategy that makes
sense
-- Examining how adaptive trial design can save time and money in running
clinical trials
-- Discussion on the importance of designing a sound subject recruitment
process to enhance trial timelines

The Medical Devices event is co-located IBC's Drug/Device Combination
Products conference to help attendees network with colleagues and gain an
edge in this increasingly competitive and dynamic market.

premarket aep

providing exclusive distribution of their patented, FDA 510(k)
cleared Prostate-63 (IVD) Prostate Cancer Diagnostic Test Kit using p63. It is the first in a
series of kits that uses p63 to diagnose prostate cancer. Markers of
basal cells are useful in diagnostic pathology particularly when examining
difficult prostate biopsies. Using strategies based on key advisors from private and academic
clinicians and pathologists specializing in urologic cancers, AsymmetRx is
committed to developing the most accurate tests for the analysis of prostate
and bladder biopsies, as well as early detection tests that in the future will
obviate the need for needle biopsies.
AsymmetRx is committed to developing systems of imaging urologic cancers
that will aid in the early treatment of such diseases, as well as therapies
based on specific targeting of malignant cells in urologic cancers. The services will be primarily provided at
Johnson; Sonny Carter Training Facility, Ellington Field, White Sands; and
facilities in Russia housing NASA and agency contractor personnel.S.

passivity stenstrom

This
kit ushers in the only FDA cleared prostate cancer test, which aids
pathologists in the differential diagnosis of prostate cancer in conjunction
with morphological findings., 1998; Signoretti et
al.461.
The medical device industry and related
technologies account for sales of more than $175 billion worldwide., partner at Hogan and Hartson, on "New
Development and Strategies for Device and Combination Product Clearances
and Approvals" will address the combined conference audience.

factors error

The
new kit, jointly developed and exclusively marketed by Signet Laboratories, is
the only FDA cleared prostate cancer diagnostic test kit.

credentialing gaspard

for the only FDA cleared, patented
test to diagnose prostate cancer

DEDHAM, Mass. (Dedham, MA), is a leading medical
diagnostics/research company specializing in the development of monoclonal
antibodies and diagnostics assays for cancer, infectious disease , and
neurodegenerative disease.
"Kelsey Seybold has a long-standing commitment to the nation 's space
program, and brings with it a superior legacy of medical care and services.

IBC's conference on Medical Devices: Strategies to Help Smaller and
Mid-Size Companies Develop and Maintain a Competitive Edge is designed to
help shape business, operational, regulatory, and reimbursement strategies
to maximize efficiency, productivity, and output. The conference is set for
September 19-20, 2005 at the Hilton Minneapolis/St.

ergonomists gaspard

, today announced the signing of an agreement with Connecticut -based
AsymmetRx, Inc.
AsymmetRx recently succeeded in developing the first FDA cleared test for
prostate cancer in needle biopsies based on the p63 antibody. More
detailed information on the company and its mission may be found at
http://www.

gaspard reviewers

The contract's three-year base period , valued at $34,473,484, begins
Dec. Paul Hotel in
Bloomington, Minnesota. A special keynote
address from Jonathan Kahan, Esq.

Medical Devices

To receive a press pass to attend this event, contact Andrew White directly
at (508) 614-1227.

err ergonomist

PRESS RELEASE Event Helps Companies Keep Pace With Growing Medical Devices Market

IBC
USA Conferences is headquartered in Westborough, Massachusetts.

sidewalks relates

Signet was created in 1989 as a commercial spinout
of Johnson + Johnson's Cambridge Research Laboratories, Inc. AsymmetRx, Inc.M.

admistration error

, Signet Laboratories,
Inc.
AsymmetRx, Inc.S."
The p63 protein is a member of the p53 family, which also includes p73,
and is expressed in the nucleus of basal cells in the epithelium.
Signet Laboratories, Inc. was founded in 2001 by scientists from Harvard University
and Johns Hopkins University to develop novel diagnostics, imaging agents, and
therapies for urologic cancers including those affecting the bladder and
prostate.915.com/Devices

cea factors

EL SEGUNDO, Calif.

Contact:
Dan Reeder
(310) 563-6728
Ref.

cea sidewalks

" Paul
Fluckiger, Signet's President + COO stated, "This is an exciting and important
opportunity for both of our companies to embark on the development of a series
of kits that provide improved diagnostics for prostate cancer patients., 2000).

About Signet Laboratories, Inc.

ergonomist workplace

About AsymmetRx
AsymmetRx, Inc.1404 Phone: 860-716-8888
Fax: 781.
Wyle is proud to be part of that legacy," said Ellis.